Proven Safe in Four Different Safety Trials

Suvaxyn^® PCV2 was proven safe in four U.S. safety studies involving 1,110 pigs.

Study Design

• Four U.S. commercial farms in Iowa, Illinois, North Carolina and Texas
• 1,110 healthy pigs, 4 weeks of age, mixed sex
  • Iowa site: 310 pigs (159 male and 151 female)
  • Illinois site: 250 pigs (11 male and 239 female)
  • North Carolina site: 250 pigs (mixed)
  • Texas site: 300 pigs (140 male and 160 female)
• Pigs were not randomized and no control groups were used
• Single 2 mL dose given IM with one of two vaccine serials
• Monitoring for 30 minutes post-vaccination (pv) for immediate reactions followed by daily observation for two weeks for any delayed reactions

Results

• None of the 1,110 pigs in this study exhibited post-vaccination reactions
• All four investigating veterinarians reported excellent safety with Suvaxyn PCV2

Conclusion

• Results from this study demonstrate the safety of Suvaxyn PCV2 under field conditions to be satisfactory when administered by IM injection to 4-week-old pigs